Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Efavirenz 600mg tablets
0503010D0AAADAD
|
Efavirenz | Efavirenz | Infections | 1 |
|
Efavirenz 100mg capsules
0503010D0AAABAB
|
Efavirenz | Efavirenz | Infections | No data available |
|
Efavirenz 200mg capsules
0503010D0AAAAAA
|
Efavirenz | Efavirenz | Infections | No data available |
|
Efavirenz 30mg/ml oral solution sugar free
0503010D0AAAEAE
|
Efavirenz | Efavirenz | Infections | No data available |
|
Efavirenz 50mg capsules
0503010D0AAACAC
|
Efavirenz | Efavirenz | Infections | No data available |
|
Sustiva 100mg capsules
0503010D0BBABAB
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 200mg capsules
0503010D0BBAAAA
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 30mg/ml oral solution
0503010D0BBAEAE
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 50mg capsules
0503010D0BBACAC
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 600mg tablets
0503010D0BBADAD
|
Sustiva | Efavirenz | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.